Samsung rolls out first digital radiology system; Minneapolis 'burbs fight over Olympus;

@FierceMedDev: ICYMI: OrbiMed kicks off $735M VC fund with device and Dx companies in mind. Story | Follow @FierceMedDev

@MarkHFierce: The U.K. is banning the use of all-metal hips at NHS Hospitals. More | Follow @MarkHFierce

@MichaelGFierce: ICYMI: IBM uses hydrogel to prolong delivery of Roche's Herceptin. More from FierceDrugDelivery | Follow @MichaelGFierce

> Samsung has begun the U.S. rollout of its first digital radiology system, which won 510(k) clearance earlier this year. Item

> The FDA granted FzioMed's petition for an independent review of its premarket application for a gel used during lumbar spine surgery, a product that remains unapproved in the U.S. after 12 years of trying. Item

> Coloplast, a Danish medical device company, reported substantial growth in profit during its fiscal 2013 fourth quarter and year. Story

> A Minneapolis suburb has approved $2 million in subsidies to lure Olympus Surgical Technologies America from a competing suburb and help it expand. Story (sub. req.)

> Advanced Medical Isotope in Washington said it has applied for 510(k) clearance for a new brachytherapy cancer product. Item

> A new article explains why few medical devices are made with young children in mind. Story

Biotech News

@FierceBiotech: Roche heralds its return to the antibiotics field with $560M Polyphor deal. More | Follow @FierceBiotech

@JohnCFierce: ICYMI over the weekend: Merck's next-gen HPV vaccine looks good in PhIII, but sales may disappoint. Story | Follow @JohnCFierce

@DamianFierce: Oral testosterone developer Lipocine swings for $11.5M in S-1. More | Follow @DamianFierce

@EmilyMFierce: ICYMI: Key HIV protein structure revealed, paving way for new HIV/AIDS vaccine efforts. Story | Follow @EmilyMFierce

> Therapeutic vaccine upstart Hookipa snags $27M round to fund PhI move. News

> Merck's 'breakthrough' hep C combo plays catch-up with promising PhII results. More

> Bristol-Myers scores first marketing application for all-oral hep C combo. Story

Pharma News

@FiercePharma: HHS gives pharma the all-clear on co-pay assistance for Obamacare patients. Article | Follow @FiercePharma

@EricPFierce: Merck layoffs roll through to West Point, Pa plant with 500 jobs slated to go over X-mas holidays. News | Follow @EricPFierce

@CarlyHFierce: ICYMI: FDA helps generic drugmakers get copies of Glaxo's Advair to market. More | Follow @CarlyHFierce

> Reuters: GlaxoSmithKline likely to escape China charges, but execs probably won't. Story

> Ex-Lilly contract sales rep sues, claiming unpaid bonuses. News

CRO News

> Venn grabs German CRO, expands Euro footprint. Item

> Charles River bucks trend with spike in preclinical sales. Story

> Covance ups expectations thanks to booming lab biz. News

> Quintiles hikes income outlook as contracts pour in. More

> InVentiv grabs Catalina Health with eye on patient adherence. Report

> Parexel's stock plunges despite spikes in revenue, profit. Article

Biotech IT News

> NuMedii taps Thomson Reuters for data to power digital discovery model. More

> GoBalto rolls out version 2.0 of Tracker software. Item

> Rhenovia creates simulation of epilepsy biology. Story

> Rare disease dictionary gives bioinformatics databases a shared language. Article

> FDA working on drug shortages smartphone app. News

> Illumina to buy bioinformatics business NextBio. Report

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.